Short Wave Folgen

ALS is a disease that destroys the nerve cells in the brain and spinal cord we need for voluntary movement. There is no cure, but now there is a newly approved medication that may slow down the disease and extend patients' lives. The drug, called Relyvrio, got its start with a couple of college students, some "ice bucket challenge" money, and a new approach to targeting this disease. Neuroscience correspondent Jon Hamilton checks in with host Emily Kwong about why some advisors aren't persuaded the drug works and how you weigh promising but limited evidence against the backdrop of a 100% fatal disease with hardly any other treatment options?Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

When a disaster like Hurricane Ian destroys a house, the clock starts ticking. It gets harder for sick people to take their medications, medical devices may stop working without electricity, excessive temperatures, mold, or other factors may threaten someone's health. Every day without stable shelter puts people in danger.The federal government is supposed to help prevent that cascade of problems, but an NPR investigation finds that the people who need help the most are often less likely to get it. Today we encore a conversation between NPR climate reporter Rebecca Hersher and Short Wave guest host Rhitu Chatterjee.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

On August 18, 2015, in Sitka, Alaska, a slope above a subdivision of homes under construction gave way. This landslide demolished a building and killed three people. Today on the show, host Emily Kwong recounts the story of the Kramer Avenue landslide and talks about how scientists and residents implemented an early warning system for landslides to prevent a future disaster.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy